4 Stocks With High Coverage Ratios Offer Safer Bets Going Into 2026

High coverage ratios and earnings growth make CAH, LTH, LMAT and FLS safer investment bets heading into 2026.

Zacks Investment Research • Dec 1, 2025

Here is Why Growth Investors Should Buy LeMaitre (LMAT) Now

LeMaitre (LMAT) is well positioned to outperform the market, as it exhibits above-average growth in financials.

Zacks Investment Research • Nov 27, 2025

New Strong Buy Stocks for November 14th

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:

Zacks Investment Research • Nov 14, 2025

LeMaitre to Participate in Upcoming Investor Conferences

BURLINGTON, Mass., Nov. 12, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will participate in three upcoming investor conferences.

GlobeNewsWire • Nov 12, 2025

Final Trade: LMAT, REGN, BA, TJX

The final trades of the day with CNBC's Melissa Lee and the 'Fast Money' traders.

CNBC Television • Nov 12, 2025

3 Reasons Why Growth Investors Shouldn't Overlook LeMaitre (LMAT)

LeMaitre (LMAT) is well positioned to outperform the market, as it exhibits above-average growth in financials.

Zacks Investment Research • Nov 11, 2025

LeMaitre Vascular, Inc. (LMAT) Q3 2025 Earnings Call Transcript

LeMaitre Vascular, Inc. ( LMAT ) Q3 2025 Earnings Call November 6, 2025 5:00 PM EST Company Participants Dorian LeBlanc - Chief Financial Officer George LeMaitre - Chairman & CEO David Roberts - President & Director Conference Call Participants Michael Sarcone - Jefferies LLC, Research Division Shaymus Contorno - Oppenheimer & Co. Inc., Research Division Rick Wise Nathan Treybeck - Wells Fargo Securities, LLC, Research Division Michael Petusky - Barrington Research Associates, Inc., Research Division Brett Fishbin - KeyBanc Capital Markets Inc., Research Division James Sidoti - Sidoti & Company, LLC Kyle Bauser - ROTH Capital Partners, LLC, Research Division Daniel Stauder - Citizens JMP Securities, LLC, Research Division Presentation Operator Hello. Good day. This is RJ, your conference operator today, and we welcome you to the LeMaitre Vascular, Inc. Q3 2025 Financial Results Conference Call.

Seeking Alpha • Nov 7, 2025

LeMaitre Q3 2025 Financial Results

BURLINGTON, Mass., Nov. 06, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq: LMAT), a provider of vascular devices, implants, and services, today reported Q3 2025 results, announced a quarterly dividend of $0.20/share, and provided guidance.

GlobeNewsWire • Nov 6, 2025

LeMaitre Vascular (LMAT) Q3 Earnings Surpass Estimates

LeMaitre Vascular (LMAT) came out with quarterly earnings of $0.62 per share, beating the Zacks Consensus Estimate of $0.57 per share. This compares to earnings of $0.49 per share a year ago.

Zacks Investment Research • Nov 7, 2025

PHG or LMAT: Which Is the Better Value Stock Right Now?

Investors interested in stocks from the Medical - Products sector have probably already heard of Royal Philips (PHG) and LeMaitre Vascular (LMAT). But which of these two stocks presents investors with the better value opportunity right now?

Zacks Investment Research • Oct 22, 2025